4.8 Article

piggyBac transposons expressing full-length human dystrophin enable genetic correction of dystrophic mesoangioblasts

Journal

NUCLEIC ACIDS RESEARCH
Volume 44, Issue 2, Pages 744-760

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/nar/gkv1464

Keywords

-

Funding

  1. Fonds voor Wetenschappelijk Onderzoek (Flanders Fund for Scientific Research
  2. FWO) [FWO G.0960.11, FWO G.0763.10]
  3. 'Aspirant' Fonds voor Wetenschappelijk Onderzoek
  4. Wetenschappelijk Fonds Willy Gepts
  5. Association Francaise contre les Myopathies (AFM)
  6. EU Framework Program 6
  7. Walter Peleman Fund (King Boudewijn Foundation)
  8. Muscular Dystrophy United Kingdom
  9. Association Monegasques contre les Myopathies
  10. EU-FP7
  11. Agentschap voor Innovatie door Wetenschap en Technological
  12. Muscular Dystrophy UK [RA3/3002, RA3/3074] Funding Source: researchfish
  13. National Institute for Health Research [ACF-2015-18-001] Funding Source: researchfish

Ask authors/readers for more resources

Duchenne muscular dystrophy (DMD) is a genetic neuromuscular disorder caused by the absence of dystrophin. We developed a novel gene therapy approach based on the use of the piggyBac (PB) transposon system to deliver the coding DNA sequence (CDS) of either full-length human dystrophin (DYS:11.1 kb) or truncated microdystrophins (MD1: 3.6 kb; MD2: 4 kb). PB transposons encoding microdystrophins were transfected in C2C12 myoblasts, yielding 65 +/- 2% MD1 and 66 +/- 2% MD2 expression in differentiated multinucleated myotubes. A hyperactive PB (hyPB) transposase was then deployed to enable transposition of the large-size PB transposon (17 kb) encoding the full-length DYS and green fluorescence protein (GFP). Stable GFP expression attaining 78 +/- 3% could be achieved in the C2C12 myoblasts that had undergone transposition. Western blot analysis demonstrated expression of the full-length human DYS protein in myotubes. Subsequently, dystrophic mesoangioblasts from a Golden Retriever muscular dystrophy dog were transfected with the large-sizePB transposon resulting in 50 +/- 5% GFP-expressing cells after stable transposition. This was consistent with correction of the differentiated dystrophic mesoangioblasts following expression of full-length human DYS. These results pave the way toward a novel non-viral gene therapy approach for DMD using PB transposons underscoring their potential to deliver large therapeutic genes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Diabetes-Induced Cellular Senescence and Senescence-Associated Secretory Phenotype Impair Cardiac Regeneration and Function Independently of Age

Fabiola Marino, Mariangela Scalise, Nadia Salerno, Luca Salerno, Claudia Molinaro, Donato Cappetta, Michele Torella, Marta Greco, Daniela Foti, Ferdinando C. Sasso, Pasquale Mastroroberto, Antonella De Angelis, Georgina M. Ellison-Hughes, Maurilio Sampaolesi, Marcello Rota, Francesco Rossi, Konrad Urbanek, Bernardo Nadal-Ginard, Daniele Torella, Eleonora Cianflone

Summary: Diabetes mellitus affects the biology of cardiac stem/progenitor cells, inhibiting their regenerative potential. By clearing senescent cells, the function of these cells can be restored, resulting in improved cardiac function in diabetic patients.

DIABETES (2022)

Article Cell & Tissue Engineering

Human iPSC model reveals a central role for NOX4 and oxidative stress in Duchenne cardiomyopathy

Robin Duelen, Domiziana Costamagna, Guillaume Gilbert, Liesbeth De Waele, Nathalie Goemans, Kaat Desloovere, Catherine M. Verfaillie, Karin R. Sipido, Gunnar M. Buyse, Maurilio Sampaolesi

Summary: This study utilized DMD patient-specific hiPSCs to model cardiomyopathy and uncovered the mechanism of oxidative stress in DMD cardiomyocytes. Targeting ROS production and preventing the detrimental effects of NOX4 on DMD CMs were proposed as promising therapeutic strategies.

STEM CELL REPORTS (2022)

Review Cell Biology

Shared and Divergent Epigenetic Mechanisms in Cachexia and Sarcopenia

Laura Yedigaryan, Martina Gatti, Vittoria Marini, Tullia Maraldi, Maurilio Sampaolesi

Summary: Cachexia and sarcopenia are significant conditions involving muscle loss, which can lead to mortality and disability. MicroRNAs play a key role in the development of muscle wasting in both cachexia and sarcopenia. Understanding the epigenetic mechanisms related to muscle loss in these conditions can help identify potential therapeutic interventions.

CELLS (2022)

Article Cell Biology

Long-term culture of patient-derived cardiac organoids recapitulated Duchenne muscular dystrophy cardiomyopathy and disease progression

Vittoria Marini, Fabiola Marino, Flaminia Aliberti, Nefele Giarratana, Enrico Pozzo, Robin Duelen, Alvaro Cortes Calabuig, Rita La Rovere, Tim Vervliet, Daniele Torella, Geert Bultynck, Maurilio Sampaolesi, Yoke Chin Chai

Summary: In this study, cardiac organoids were generated from patient-derived induced pluripotent stem cells to model Duchenne Muscular Dystrophy (DMD)-related cardiomyopathy. The organoids exhibited progressive loss of sarcoglycan localization, endoplasmic reticulum stress, cardiomyocyte deterioration, fibrosis, and aberrant adipogenesis over time. RNA sequencing analysis identified distinct transcriptomic profiles and crucial miRNAs associated with DMD-related cardiomyopathy. These findings suggest the potential for developing in vitro 3D human cardiac-mimics to study DMD-related cardiomyopathies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Medicine, Research & Experimental

Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling

SungWoo Choi, Giulia Ferrari, Louise A. Moyle, Kirsty Mackinlay, Naira Naouar, Salma Jalal, Sara Benedetti, Christine Wells, Francesco Muntoni, Francesco Saverio Tedesco

Summary: Muscle satellite stem cells (MuSCs) play a crucial role in muscle growth and regeneration. Researchers have found that DLL4 and PDGF-BB can enhance the migration capacity of myogenic progenitors derived from human induced pluripotent stem cells (hiPSCs), bringing hiPSCs closer to potential applications in muscle gene and cell therapies.

EMBO MOLECULAR MEDICINE (2022)

Article Cell Biology

Autologous iPSC-Derived Human Neuromuscular Junction to Model the Pathophysiology of Hereditary Spastic Paraplegia

Domiziana Costamagna, Valerie Casters, Marc Beltra, Maurilio Sampaolesi, Anja Van Campenhout, Els Ortibus, Kaat Desloovere, Robin Duelen

Summary: This study generated in vitro human neuromuscular junctions (NMJs) using a microfluidic strategy from patient-specific induced pluripotent stem cell (hiPSC) lines to model disease-relevant neuropathologic processes in hereditary spastic paraplegia (HSP). The unique strength of this NMJ model is its ability to generate lower motor neurons (MNs) and myotubes from autologous hiPSC origin while maintaining the genetic background of HSP patient donors. The study found that HSP-derived lines exhibited axonal swellings, reduced levels of SPASTIN protein, and impaired NMJ profiles, offering unique tools to study the pathologic mechanisms of HSP.

CELLS (2022)

Article Multidisciplinary Sciences

PGC-1α in the myofibers regulates the balance between myogenic and adipogenic progenitors affecting muscle regeneration

Marc Beltra, Fabrizio Pin, Domiziana Costamagna, Robin Duelen, Alessandra Renzini, Riccardo Ballaro, Lorena Garcia-Castillo, Ambra Iannuzzi, Viviana Moresi, Dario Coletti, Maurilio Sampaolesi, Fabio Penna, Paola Costelli

Summary: This study reveals that overexpression of PGC-1 alpha in myofibers alters the proportion of MuSCs and ISCs, leading to enhanced fusion of myogenic progenitors with recipient myofibers and reduced adipogenesis in skeletal muscle.

ISCIENCE (2022)

Article Cell Biology

Cardiomyocyte differentiation from human induced pluripotent stem cells is delayed following knockout of Bcl-2

Tim Vervliet, Robin Duelen, Ankit Pradhan, Rita La Rovere, H. Llewelyn Roderick, Maurilio Sampaolesi

Summary: Bcl-2 plays a crucial role in the differentiation of cardiomyocytes, and its loss delays the induction of pluripotent stem cells into cardiomyocytes, leading to reduced expression and activity of the cardiomyocyte Ca2+ toolkit, as well as decreased c-Myc expression and nuclear localization in the early phase of cardiac differentiation.

JOURNAL OF CELL SCIENCE (2023)

Review Genetics & Heredity

Mesoangioblasts at 20: From the embryonic aorta to the patient bed

Giulio Cossu, Rossana Tonlorenzi, Silvia Brunelli, Maurilio Sampaolesi, Graziella Messina, Emanuele Azzoni, Sara Benedetti, Stefano Biressi, Chiara Bonfanti, Laricia Bragg, Jordi Camps, Ornella Cappellari, Marco Cassano, Fabio Ciceri, Marcello Coletta, Diego Covarello, Stefania Crippa, M. Gabriella Cusella-De Angelis, Luciana De Angelis, Arianna Dellavalle, Jordi Diaz-Manera, Daniela Galli, Francesco Galli, Cesare Gargioli, Mattia F. M. Gerli, Giorgia Giacomazzi, Beatriz G. Galvez, Hidetoshi Hoshiya, Maria Guttinger, Anna Innocenzi, M. Giulia Minasi, Laura Perani, Stefano C. Previtali, Mattia Quattrocelli, Martina Ragazzi, Urmas Roostalu, Giuliana Rossi, Raffaella Scardigli, Dario Sirabella, Francesco Saverio Tedesco, Yvan Torrente, Gonzalo Ugarte

Summary: In 2002, we discovered a group of vessel-associated progenitors called mesoangioblasts (MABs). Studies over the past decade have shown that muscle development and regeneration are more complex than previously thought. We identified the origin of MABs as partly from the embryonic aorta and later from the microvasculature of skeletal muscle. MABs could be expanded in vitro and cross the vessel wall, making them a potential choice for cell therapy of muscular dystrophies.

FRONTIERS IN GENETICS (2023)

Article Biochemistry & Molecular Biology

Human Neuromuscular Junction on a Chip: Impact of Amniotic Fluid Stem Cell Extracellular Vesicles on Muscle Atrophy and NMJ Integrity

Martina Gatti, Katarina Stoklund Dittlau, Francesca Beretti, Laura Yedigaryan, Manuela Zavatti, Pietro Cortelli, Carla Palumbo, Emma Bertucci, Ludo van den Bosch, Maurilio Sampaolesi, Tullia Maraldi

Summary: Neuromuscular junctions are important for communication between spinal motor neurons and skeletal muscle, and their vulnerability in degenerative diseases like muscle atrophy is poorly understood. Recent studies have shown the regenerative potential of stem cells and extracellular vesicles in muscle fiber regeneration, but their role in counteracting NMJ perturbations is not clear. In this study, a co-culture system was used to investigate the effects of AFSC-derived EVs on NMJ alterations induced by muscle atrophy. The presence of EVs reduced morphological and functional defects and prevented oxidative stress in atrophic myotubes. This study provides a valuable tool for studying MN and myotube interactions and demonstrates the efficacy of AFSC-EVs in counteracting NMJ perturbations.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemical Research Methods

3D human induced pluripotent stem cell-derived bioengineered skeletal muscles for tissue, disease and therapy modeling

Luca Pinton, Moustafa Khedr, Valentina M. Lionello, Shilpita Sarcar, Sara M. Maffioletti, Sumitava Dastidar, Elisa Negroni, SungWoo Choi, Noreen Khokhar, Anne Bigot, John R. Counsell, Andreia Sofia Bernardo, Peter S. Zammit, Francesco Saverio Tedesco

Summary: This article presents a protocol for the modular 3D bioengineering of multilineage skeletal muscles from human induced pluripotent stem cells, and provides assays to characterize morphological and functional features of the artificial muscle constructs. These bioengineered muscles have the ability to recapitulate morphological and functional features of human skeletal muscle, making them a powerful tool for studying muscle pathology and developing neuromuscular and musculoskeletal therapies.

NATURE PROTOCOLS (2023)

Review Physiology

Extracellular vesicles and Duchenne muscular dystrophy pathology: Modulators of disease progression

Laura Yedigaryan, Maurilio Sampaolesi

Summary: Duchenne muscular dystrophy (DMD) is a severe disorder caused by mutations in the dystrophin gene, leading to muscle fiber degradation and weakness. Extracellular vesicles (EVs), secreted by cells, may play a role in DMD pathology and could serve as biomarkers for specific pathological processes. Additionally, EVs can be used for targeted cargo delivery and inhibition of EV secretion, providing potential therapeutic strategies for DMD.

FRONTIERS IN PHYSIOLOGY (2023)

Article Cell Biology

Ex vivo adult stem cell characterization from multiple muscles in ambulatory children with cerebral palsy during early development of contractures

M. Corvelyn, J. Meirlevede, J. Deschrevel, E. Huyghe, E. De Wachter, G. Gayan-Ramirez, M. Sampaolesi, A. Van Campenhout, K. Desloovere, D. Costamagna

Summary: Cerebral palsy (CP) is a common condition causing lifelong physical disability in children. Previous studies have shown changes in muscle properties, such as decreased number of satellite cells and altered fusion capacity. However, these observations vary widely among studies, possibly due to differences in patient population, lack of control data, methodology, and muscle assessment. This study aimed to further investigate CP muscle pathology and confirm previous findings of increased satellite cell fusion capacity.

DIFFERENTIATION (2023)

Review Biotechnology & Applied Microbiology

Hemophilia Gene Therapy: The End of the Beginning?

Dries De Wolf, Kshitiz Singh, Marinee K. Chuah, Thierry Vandendriessche

Summary: Extensive preclinical research has led to the recent regulatory approval of gene therapy products for hemophilia. Roctavian and Hemgenix have shown significant efficacy and safety in clinical trials, resulting in increased levels of clotting factors and reduced bleeding episodes for patients. However, there is variability in patient response and short-term liver inflammation was observed. Longer follow-up studies are needed to determine if lifelong expression of clotting factors can be achieved. Next-generation gene editing technologies offer new prospects for a sustained cure for hemophilia.

HUMAN GENE THERAPY (2023)

Article Cell Biology

Botulinum Toxin Treatment of Adult Muscle Stem Cells from Children with Cerebral Palsy and hiPSC-Derived Neuromuscular Junctions

Domiziana Costamagna, Valeria Bastianini, Marlies Corvelyn, Robin Duelen, Jorieke Deschrevel, Nathalie De Beukelaer, Hannah De Houwer, Maurilio Sampaolesi, Ghislaine Gayan-Ramirez, Anja Van Campenhout, Kaat Desloovere

Summary: This study aims to clarify the impact of BoNT on growing muscles by analyzing the effect of BoNT on muscle stem cells in vitro, and by following the effect of in vivo BoNT administration on these cells obtained from children with CP. The results show that in vitro BoNT does not affect muscle differentiation or collagen production, but it does affect neuromuscular junctions. Further studies are needed to understand the long-term and collateral effects of BoNT in the muscles of children with CP.

CELLS (2023)

No Data Available